CRNX
Crinetics Pharmaceuticals
$83.85
+$0.12 (+0.14%)Jul 27, 2026
Key metrics
The numbers that frame CRNX today
- Market cap
- $8.84B
- P/E (TTM)
- -17.8
- EV / FCF
- -20.9
- Gross margin
- 92.9%
- EV / Sales
- 485.6
- ROIC
- -43.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $25.83
- 52wk High
- $84.00
Growth
Revenue and earnings trend for CRNX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRNX
Is Crinetics Pharmaceuticals a good buy?
No. Crinetics Pharmaceuticals has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Crinetics Pharmaceuticals is selling at a high price.
What is the market capitalization of CRNX?
Crinetics Pharmaceuticals's market capitalization is $8.84B.
What is the P/E ratio for CRNX stock?
Crinetics Pharmaceuticals's current P/E ratio is -17.8.
What is the 52-week high for CRNX stock?
The 52-week high for Crinetics Pharmaceuticals is $84.00. The current close of $83.85 is 0.2% below that high.
What is the 52-week low for CRNX stock?
The 52-week low for Crinetics Pharmaceuticals is $25.83. The current close of $83.85 is 224.6% above that low.
Does CRNX stock pay dividends?
Crinetics Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRNX?
Crinetics Pharmaceuticals's Debt / Equity ratio is 0.04.